Alzheimer's Disease
Showing NaN - NaN of 92
Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)
Completed
- Alzheimer's Disease
- florbetapir F 18
- +2 more
-
Phoenix, Arizona
- +26 more
Sep 3, 2020
Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)
Completed
- Alzheimer's Disease
- Flortaucipir F18
- PET Scan
-
Phoenix, Arizona
- +30 more
Sep 3, 2020
Alzheimer's Disease Trial in United States (Flortaucipir F18, PET Scan)
Completed
- Alzheimer's Disease
- Flortaucipir F18
- PET Scan
-
Phoenix, Arizona
- +21 more
Aug 7, 2020
Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
- Placebo
-
Tucson, Arizona
- +31 more
Jul 31, 2020
Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Crenezumab)
Terminated
- Alzheimer's Disease
-
Newport Beach, California
- +65 more
Jun 25, 2020
Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)
Terminated
- Alzheimer's Disease
- Behavioral Variant Frontotemporal Dementia
-
Phoenix, Arizona
- +134 more
May 15, 2020
Alzheimer's Disease Trial in Worldwide (RVT-101 35 mg tablets)
Terminated
- Alzheimer's Disease
- RVT-101 35 mg tablets
-
Phoenix, Arizona
- +168 more
Apr 14, 2020
Alzheimer's Disease, Healthy Volunteer Trial in United States (BIIB076, Placebo)
Completed
- Alzheimer's Disease
- Healthy Volunteer
- BIIB076
- Placebo
-
Hallandale Beach, Florida
- +7 more
Mar 23, 2020
Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)
Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)
Terminated
- Alzheimer's Disease
- Group 1 ELND005
- Group 2 ELND005
-
Birmingham, Alabama
- +45 more
Oct 17, 2019
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)
Completed
- Alzheimer's Disease
- Idalopirdine 60 mg
-
Birmingham, Alabama
- +257 more
Aug 9, 2018
Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)
Completed
- Alzheimer's Disease
- Bryostatin 1
- Placebo
-
Phoenix, Arizona
- +28 more
Jun 6, 2018